SCHEMBL17599555

SCHEMBL17599555

Cc1cc(C)c(C)c(S(=O)(=O)Nc2cc(C=CC(=O)OC(C)(C)C)cc3ccccc23)c1C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 5/20 0.45
▸ KDM4E B2RXH2 4/20 0.45
▸ MEN1 O00255 4/20 0.45
▸ ALDH1A1 P00352 2/20 0.45
▸ HPGD P15428 2/20 0.45
▸ HSD17B10 Q99714 2/20 0.45
▸ CRHBP P24387 1/20 0.45
▸ CRHR2 Q13324 1/20 0.45
▸ KEAP1 Q14145 3/20 0.38
▸ NFE2L2 Q16236 1/20 0.38
▸ GAA P10253 2/20 0.38
▸ TSHR P16473 1/20 0.38
▸ POLB P06746 1/20 0.37
▸ TDP1 Q9NUW8 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ MAPT P10636 2/20 0.37
▸ TP53 P04637 1/20 0.37
▸ LMNA P02545 2/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ HTT P42858 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17599554 1.00 KMT2A (0.45) KMT2AKDM4EMEN1ALDH1A1HPGD
SCHEMBL17599535 0.85 KDM4E (0.53) KMT2AKDM4EMEN1ALDH1A1HPGD
SCHEMBL17599538 0.85 KDM4E (0.53) KMT2AKDM4EMEN1ALDH1A1HPGD
SCHEMBL17599542 0.83 KEAP1 (0.48) KMT2AKDM4EMEN1ALDH1A1HPGD
SCHEMBL17599541 0.83 KEAP1 (0.48) KMT2AKDM4EMEN1ALDH1A1HPGD
SCHEMBL17614108 0.80 KMT2A (0.34) KMT2AKDM4EMEN1L3MBTL1LMNA
SCHEMBL17599545 0.75 ALDH1A1 (0.47) KMT2AKDM4EMEN1ALDH1A1HPGD
SCHEMBL17599472 0.74 ALDH1A1 (0.41) KMT2AKDM4EMEN1ALDH1A1HPGD
SCHEMBL17159202 0.73 KDM4E (0.44) KMT2AKDM4EMEN1ALDH1A1HPGD
SCHEMBL17159204 0.73 KDM4E (0.44) KMT2AKDM4EMEN1ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2998292-A1 Naphthyl sulfonamide derivatives as KEAP-1 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders SANOFI (FR) 2016-03-23 — — EP disclosed
Send feedback